Sutent
Pfizer halts Sutent colon cancer trial
July 2, 2009Research and Development, Sales and Marketing Cancer, Pfizer, Sutent
Pfizer has halted a phase III trial for its oncology hope Sutent, after it failed to show significant improvement in …
Pfizer halts Sutent head-to-head trial
April 6, 2009Research and Development, Sales and Marketing Cancer, Pfizer, Sutent
Pfizer has halted a late-stage breast cancer trial between Sutent and Roche's Xeloda, after the study failed to show significant …
NICE recommends Pfizer’s Sutent
March 26, 2009Research and Development NICE, Pfizer, Sutent
NICE has issued its final guidance on Pfizer's Sutent, recommending the kidney cancer drug as a first-line treatment. The drug …
Pfizer switches agencies in time for Sutent’s UK launch
August 18, 2006Medical Communications Reynolds-Mackenzie, Sutent
Pfizer has enlisted PR agency Reynolds-Mackenzie to support the UK launch and subsequent development of its potential blockbuster kidney cancer …
Latest content
Aiforia deal to expand access to pathology AI
October 22, 2026
SMC accepts atogepant for acute migraine treatment in Scotland
October 22, 2026
New CCO Ogburn joins Cori Clinical
October 21, 2026
